[Code of Federal Regulations]

[Title 42, Volume 1]

[Revised as of October 1, 2006]

From the U.S. Government Printing Office via GPO Access

[CITE: 42CFR52e.5]



[Page 217]

 

                         TITLE 42--PUBLIC HEALTH

 

    CHAPTER I--PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN 

                                SERVICES

 

PART 52e_NATIONAL HEART, LUNG, AND BLOOD INSTITUTE GRANTS FOR PREVENTION AND CONTROL PROJECTS--Table of Contents

 

Sec.  52e.5  What are the project requirements?



    (a) An approvable application must demonstrate to the satisfaction 

of the Director that:

    (1) With respect to applications relating to projects covered by 

Sec.  52e.1(a)(1), the techniques or procedures to be demonstrated and 

evaluated have been found safe and effective in the research setting 

and, based upon research findings, appear to have the potential for 

general applicability to the prevention, diagnosis, or treatment of 

heart, blood vessel, lung, or blood diseases;

    (2) With respect to applications relating to projects covered by 

Sec.  52e.1(a)(2) and Sec.  52e.1(a)(3), the project will include 

development and evaluation of one or more methods for educating health 

practitioners or the public concerning advances in the prevention, 

diagnosis, or treatment of such diseases; and

    (3) The nature of the project is such that its completion may be 

anticipated within the project period, or such other period as may be 

specified in the application.

    (b) The project must, in the judgment of the Director, be necessary 

for cooperation by the National Heart, Lung, and Blood Institute with 

one or more other Federal Health agencies, State, local or regional 

public health agencies, or nonprofit private health agencies in the 

diagnosis, prevention, or treatment of heart, blood vessel, lung or 

blood diseases.



[45 FR 12249, Feb. 25, 1980, as amended at 58 FR 54298 and 54299, Oct. 

21, 1993]